[1] Agulnik M, Cohen EW, Cohen RB, et a1. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands[J]. J Clin Oncol,2007,25(25):3978-3984.
[2] 于世凤.口腔组织病理学[M].6版.北京:人民卫生出版社,2007:288-290.
[3] Chen KY, Mohr RM, Silverman CL. Interstitial iodine 125 in advanced recurrent squamous cell carcinoma of the head and neck with follow-up evaluation of carotid artery by ultrasound[J]. Ann Otol Rhinol Laryngol,1996, 105(12):955-961.
[4] Park RL, Liberman FZ, Lee DL, et al. Iodine-125 seed implantation as an adjunct to surgery in advanced recurrent squamous cell cancer of the head and neck [J]. Laryngoscope,1991, 101(4):405-410.
[5] Chen AM, Bucci MK, Weinberg V, et al. Adenoid cystic carcinoma of the head and neck treated by surgery with or without postoperative radiation therapy: prognostic features of recurrence[J]. Int J Radiat Oncol Biol Phys,2006, 66(1):152-159.
[6] Balamucki CJ, Amdur RJ, Werning JW, et al. Adenoid cystic carcinoma of the head and neck[J]. Am J Otolaryngol, 2012, 33(5): 510-518.
[7] Papaspyrou G, Hoch S, Rinaldo A, et al. Chenmotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck:a review[J]. Head Neck,2011,33(6):905-911.
[8] Teishima J, Kenjo M, Kobatake K, et al. Six-year experience of permanent prostate brachytherapy for clinically localized prostate cancer [J]. Hiroshima J Med Sci,2011, 60(3):51-56.
[9] Zhang J, Zhang JG, Song TL, et a1. 125I seed implant brachytherapy-assisted surgery with preservation of the facial nerve for treatment of malignant parotid gland tumors [J]. Int J Oral Maxillofac Surg, 2008, 37(6): 515-520.
[10] EI Majdoub F, Simon T, Hoevels M, et al. Interstitial brachytherapy using stereotactic implanted (125)iodine seeds for recurrent medulloblastoma[J]. Clin Oncol(R Coll Radiol),2011, 23(8):532-537.
[11] Stewart AJ, O'Farrell DA, Mutyala S, et al. Severe toxicity after permanent radioactive seed implantation for mediastinal carcinoid tumors [J]. Brachytherapy,2007, 6(1):58-61.
[12] Jiang YL, Meng N, Wang JJ, et al. Percutaneous computed tomography/ ultrasonography-guided permanent iodine-125 implantation as salvage therapy for recurrent squamous cell cancers of head and neck [J]. Cancer Biol Ther, 2010, 9(12):959-966.
[13] Ndlebe T, Neumann RD, Panyutin IG. Study of charge transport mechanisms in 125I-induced DNA damage at various temperatures[J]. Int J Radiat Biol,2012，88（12）：941-947.
[14] Würschmidt F, Fassbender T, Beck-Bornholdt HP.Combined fractionated external beam radiotherapy and low-dose-rate iodine-125 seeds in an experimental tumor system[J]. Straldenther Onkol, 2000, 176(11):524-527.
[15] Chino K, Silvain D, Grace A, et al. Fesibility and safety of outpatient brachytherapy in 37 patients with brain tumors using the GliaSite Radiation Therapy System[J]. Med Phys, 2008, 35 (7):3383-3388.
[16] 吕淑珍,张杰,赵京华.联合术后放射性粒子125I组织间植入治疗涎腺腺样囊性癌的初步观察[J]. 现代口腔医学杂志,2009,23(5) :550-551.
[17] Jiang P, Jiang Y, Wang JJ, et al. Percutaneous ultrasonography-guided permanent iodine-125 implan-tation as salvage therapy for recurrent head and neck carcimonas[J]. Cancer Biother Radiopham, 2011. 26(6):753-757.
[18] Zheng L, Zhang J, Zhang J, et al. Preliminary results of (125)I interstitial brachytherapy for locally recurrent parotid gland cancer in previously irradiated patients [J]. Head Neck, 2012, 34（10）：1445-1449.
[19] Stannard CE, Hering E, Hough J, et al. Post-operativetreatment of malignant salivary gland tumours of the palate with iodine-125 brachytherapy[J]. Radiother Oncol, 2004, 73(3):307-311.
[20] 孟箭, 孟庆飞, 司亚萌, 等.赝复体联合放射性粒子植入治疗腭部恶性肿瘤[J]. 口腔颌面外科杂志,2012,22(1):30-32.
|